NASDAQ: IVPInspire Veterinary Partners Inc Stock
$2.62+0.08 (+3.15%)
Updated May 17, 2024
IVP Price
$2.62
Fair Value Price
N/A
Market Cap
$2.51M
52 Week Low
$2.36
52 Week High
$410.00
P/E
-0.01x
P/B
9.3x
P/S
0.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$17.22M
Earnings
-$16.68M
Gross Margin
20.7%
Operating Margin
-81.99%
Profit Margin
-99.6%
Debt to Equity
85.7
Operating Cash Flow
-$7M
Beta
-0.68
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IVP Overview
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IVP is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVP is good value based on its book value relative to its share price (9.3x), compared to the US Personal Services industry average (11.13x)
P/B vs Industry Valuation
IVP is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IVP due diligence checks available for Premium users.
Be the first to know about important IVP news, forecast changes, insider trades & much more!
IVP News
Valuation
IVP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
38.95x
Market
30.97x
IVP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.3x
Industry
11.13x
IVP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IVP's financial health
Profit margin
Revenue
$4.8M
Net Income
-$3.4M
Profit Margin
-75.3%
IVP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IVP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$23.4M
Liabilities
$23.1M
Debt to equity
85.7
IVP's short-term liabilities ($8.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVP's long-term liabilities ($14.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.2M
Investing
-$156.9k
Financing
$3.2M
IVP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
IVP vs Personal Service Stocks
Inspire Veterinary Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.